[Advances in grey platelet syndrome].
Xuan M, Yang RC.
Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):502-4.
Grey platelet syndrome.
Aronson I, Du Toit JM, Jacobs P.
Lancet. 1994 Oct 29;344(8931):1233-4. doi: 10.1016/s0140-6736(94)90551-7.
Risk prediction for clonal cytopenia: multicenter real-world evidence.
Xie Z, Komrokji R, Al Ali N, Regelson A, Geyer S, Patel A, Saygin C, Zeidan AM, Bewersdorf JP, Mendez L, Kishtagari A, Zeidner JF, Coombs CC, Madanat YF, Chung S, Badar T, Foran J, Desai P, Tsai C, Griffiths EA, Al Malki MM, Amanam I, Lai C, Deeg HJ, Ades L, Arana Yi C, Osman AEG, Dinner S, Abaza Y, Taylor J, Chandhok N, Soong D, Brunner AM, Carraway HE, Singh A, Elena C, Ferrari J, Gallì A, Pozzi S, Padron E, Patnaik MM, Malcovati L, Savona MR, Al-Kali A.
Blood. 2024 Nov 7;144(19):2033-2044. doi: 10.1182/blood.2024024756.
Grey platelet syndrome misdiagnosed as ITP.
Perez Botero J, Im R, Chen D, Patnaik MM.
Br J Haematol. 2016 Jun;173(5):662. doi: 10.1111/bjh.14079. Epub 2016 May 12.
Single-cell multi-omics analysis of the immune response in COVID-19.
Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, Bach K, Sungnak W, Worlock KB, Yoshida M, Kumasaka N, Kania K, Engelbert J, Olabi B, Spegarova JS, Wilson NK, Mende N, Jardine L, Gardner LCS, Goh I, Horsfall D, McGrath J, Webb S, Mather MW, Lindeboom RGH, Dann E, Huang N, Polanski K, Prigmore E, Gothe F, Scott J, Payne RP, Baker KF, Hanrath AT, Schim van der Loeff ICD, Barr AS, Sanchez-Gonzalez A, Bergamaschi L, Mescia F, Barnes JL, Kilich E, de Wilton A, Saigal A, Saleh A, Janes SM, Smith CM, Gopee N, Wilson C, Coupland P, Coxhead JM, Kiselev VY, van Dongen S, Bacardit J, King HW; Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID-19 BioResource Collaboration; Rostron AJ, Simpson AJ, Hambleton S, Laurenti E, Lyons PA, Meyer KB, Nikolić MZ, Duncan CJA, Smith KGC, Teichmann SA, Clatworthy MR, Marioni JC, Göttgens B, Haniffa M.
Nat Med. 2021 May;27(5):904-916. doi: 10.1038/s41591-021-01329-2. Epub 2021 Apr 20.
Gray platelet syndrome.
Bain BJ, Bhavnani M.
Am J Hematol. 2011 Dec;86(12):1027. doi: 10.1002/ajh.22055. Epub 2011 Jul 28.
Gray platelet syndrome.
Michelson AD.
Blood. 2013 Jan 10;121(2):250. doi: 10.1182/blood-2012-09-455550.
Gray platelet syndrome.
Wills EJ.
Ultrastruct Pathol. 1989 Jul-Aug;13(4):451-5. doi: 10.3109/01913128909048495.
Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24.
Khatib-Massalha E, Di Buduo CA, Chédeville AL, Ho YH, Zhu Y, Grockowiak E, Date Y, Khuat LT, Fang Z, Quesada-Salas J, Carrillo Félez E, Migliavacca M, Montero I, Pérez-Simón JA, Balduini A, Méndez-Ferrer S.
Blood. 2025 Aug 7;146(6):717-731. doi: 10.1182/blood.2024027455.
[Grey platelet disease].
Silvestre J, Batalha V, Martins A, Duque S, Freitas P, Dias AR, Campos L.
Acta Med Port. 2009 Jan-Feb;22(1):99-104. Epub 2009 Mar 25.
